Global Asthma Competitive Landscape Report 2023: Comprehensive Insights on 110+ Companies and 125+ Drugs
April 28, 2023 07:03 ET | Research and Markets
Dublin, April 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Asthma- Competitive landscape, 2023" report...
Global Asthma Drugs Market
Global Asthma Drugs Market Forecast to 2028 - Opportunities with Commercialization of Biologics
June 21, 2022 05:38 ET | Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Global Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Medications, Route of Administration, and Distribution Channels"...
New Asthma Drug Nuca
New Asthma Drug Nucala (Mepolizamab) Available Now to Treat Severe Asthma
January 20, 2017 03:00 ET | Allergy Partners
ASHEVILLE, N.C., Jan. 20, 2017 (GLOBE NEWSWIRE) -- Earlier this year, the FDA has approved Nucala as add on therapy for maintenance treatment in patients with severe eosinophilic asthma in patients...